Travers, J.
Rochman, M.
Caldwell, J. M.
Besse, J. A.
Miracle, C. E.
Rothenberg, M. E.
Article History
Received: 30 August 2017
Accepted: 23 November 2017
First Online: 14 December 2017
Competing Interests
: M.E.R. is a consultant for N.K.T. Therapeutics, Pulm One, Spoon Guru, Celgene, Shire, Astra Zeneca, and Novartis and has an equity interest in the first three listed and Immune Pharmaceuticals and royalties from reslizumab (Teva Pharmaceuticals). M.E.R. is an inventor of several patents, owned by Cincinnati Children’s. All of the other authors have no potential conflicts to disclose.